Baudax Bio (BXRX) Misses Q2 EPS by $1.07

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. AMZN
2. INTC
3. RDDT
4. COIN
5. PINS
6. FSLR
7. DASH
8. SYK
9. ALNY
10. SBUX

Go back to Baudax Bio (BXRX) Misses Q2 EPS by $1.07

Baudax Bio Reports Second Quarter 2020 Financial Results

August 10, 2020 7:15 AM EDT

Commenced Commercial Launch of ANJESO® in the U.S.

Awarded J-Code from CMS

Executed Contract with a top National GPO for hospital purchases, Vizient, and one of the top 3 IDNs Nationally

Secured $50 Million Credit Facility

MALVERN, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today reported financial results for the three and six months ended June 30, 2020.

... More